Comparison:
Sperax
SPA
Algorithmic Stablecoin Protocol
$0.007844
-1.91% - Trading Volume(24h) -3.95% $3,228,837.97
- Circulating Market Cap$19,048,582.31 #901
- Fully Diluted Valuation$38,876,972.5
- Circulating Supply2,429,446,498.344 SPA
- Total Supply4,956,123,483.049 SPA
- All-time High $0.2394 (Mar 23, 2022)
- All-time Low $0.003286 (Sep 22, 2023)
- Max Supply 5,000,000,000 SPA
- Contract Address
0xb4a3...9008 - Supported Exchanges
+8 - Launched Aug 2020
Analytics
Performances
Comparison
Essentials
Details
Team
Milestones
Financials
Fundraising
Tokenomics
Top Holders
Trade
Open Markets
News
Related News
𝕏 Data
Follow Updates
Follow Lists
Performances
| 1h | 24h | 7d | 30d | 60d | 90d |
| 0.43% | 1.91% | 0.83% | 18.55% | 27.60% | 12.24% |
Comparison
Details
Sperax is a yield-bearing crypto-collateralized algorithmic stablecoin protocol on the Arbitrum network. USD holders benefit from native auto-yield, meaning that they automatically earn yield without having to stake or claim. The yield is generated organically from the collateral deployed on external DeFi protocols, such as Curve Finance.
Milestones
2020-01-01
Sperax raised $ 6 M in Seed round
2020-08
SPA is live for trading
2020-08-20
Sperax raised $ 4.7 M in funding round
2021-12-29
Sperax raised $ 6 M in funding round
2023-01-12
Sperax completed a new funding round
Share to 
Share poster
Share posterTokenomics
Top Holders
Open Markets
--
# | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
|---|---|---|---|---|---|---|---|
No Data | |||||||
𝕏 Follow Updates
No Data𝕏 Follow Lists
$0.007844
-1.91% 
- Trading Volume(24h) -3.95% $3,228,837.97
- Circulating Market Cap$19,048,582.31 #901
- Fully Diluted Valuation$38,876,972.5
- Circulating Supply2,429,446,498.344 SPA
- Total Supply4,956,123,483.049 SPA
- All-time High $0.2394 (Mar 23, 2022)
- All-time Low $0.003286 (Sep 22, 2023)
- Max Supply 5,000,000,000 SPA
- Total Raised $16M
- Contract Address 0xb4a3...9008
- Supported Exchanges +8
- Launched Aug 2020
Rate Sperax
Rated by 0 users
What’s your take on Sperax? Share your review.
Comments are posted by users and do not constitute financial advice
